Markus Clemenz

2.1k total citations · 1 hit paper
15 papers, 1.7k citations indexed

About

Markus Clemenz is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Markus Clemenz has authored 15 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Markus Clemenz's work include Peroxisome Proliferator-Activated Receptors (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Adipose Tissue and Metabolism (4 papers). Markus Clemenz is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Adipose Tissue and Metabolism (4 papers). Markus Clemenz collaborates with scholars based in Germany, France and United States. Markus Clemenz's co-authors include Ulrich Kintscher, Thomas Unger, Anna Foryst‐Ludwig, Martin Hartge, Michael Schupp, C Sprang, Maxim Krikov, Nikolaus Marx, Katharina Heß and Vinzenz Hombach and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and Hypertension.

In The Last Decade

Markus Clemenz

15 papers receiving 1.7k citations

Hit Papers

T-lymphocyte Infiltration in Visceral Adipose Tissue 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. T-lymphocyte Infiltration in Visceral Adipose Tissue
    2008 562 citations Ulrich Kintscher, Martin Hartge et al. Arteriosclerosis Thrombosis and Vascular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Clemenz Germany 14 733 606 601 364 335 15 1.7k
Tufail Syed United States 11 796 1.1× 520 0.9× 522 0.9× 443 1.2× 697 2.1× 13 2.1k
Jason DeFuria United States 13 1.1k 1.5× 933 1.5× 447 0.7× 226 0.6× 196 0.6× 18 2.1k
Agnès Pernin Switzerland 13 733 1.0× 811 1.3× 818 1.4× 379 1.0× 157 0.5× 16 2.0k
Adam B. Mayerson United States 7 625 0.9× 587 1.0× 713 1.2× 168 0.5× 464 1.4× 9 1.6k
Toshiyuki Hibuse Japan 17 656 0.9× 679 1.1× 645 1.1× 488 1.3× 478 1.4× 19 1.9k
Nanlan Luo United States 14 1.1k 1.5× 781 1.3× 626 1.0× 332 0.9× 134 0.4× 16 1.9k
Federica Sentinelli Italy 20 695 0.9× 363 0.6× 300 0.5× 264 0.7× 412 1.2× 52 1.4k
Martin Hartge Germany 7 586 0.8× 423 0.7× 258 0.4× 199 0.5× 201 0.6× 7 1.2k
Heekyung Chung United States 18 499 0.7× 623 1.0× 525 0.9× 157 0.4× 108 0.3× 28 1.6k
Silvia Gogg Sweden 13 738 1.0× 935 1.5× 671 1.1× 269 0.7× 159 0.5× 18 1.7k

Countries citing papers authored by Markus Clemenz

Since Specialization
Citations

This map shows the geographic impact of Markus Clemenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Clemenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Clemenz more than expected).

Fields of papers citing papers by Markus Clemenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Clemenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Clemenz. The network helps show where Markus Clemenz may publish in the future.

Co-authorship network of co-authors of Markus Clemenz

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Clemenz. A scholar is included among the top collaborators of Markus Clemenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Clemenz. Markus Clemenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kappert, Kai, Anna Foryst‐Ludwig, Markus Clemenz, et al.. (2017). AT1-receptor blockade attenuates outward aortic remodeling associated with diet-induced obesity in mice. Clinical Science. 131(15). 1989–2005. 25 indexed citations
2.
Böhm, Christian, Verena Benz, Markus Clemenz, et al.. (2013). Sexual dimorphism in obesity-mediated left ventricular hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 305(2). H211–H218. 24 indexed citations
3.
Clemenz, Markus, et al.. (2012). A flat and cost effective actuator based on superabsorbent polymer driving a skin attachable drug delivery system. Smart Materials and Structures. 21(10). 105002–105002. 5 indexed citations
4.
Benz, Verena, Markus Clemenz, Anna Foryst‐Ludwig, et al.. (2011). Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis. Diabetes. 61(2). 513–523. 70 indexed citations
5.
Foryst‐Ludwig, Anna, Martin Hartge, Markus Clemenz, et al.. (2010). PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice. Cardiovascular Diabetology. 9(1). 64–64. 51 indexed citations
6.
Goebel, Matthias, Markus Clemenz, Bart Staels, et al.. (2009). Characterization of New PPARγ Agonists: Analysis of Telmisartan’s Structural Components. ChemMedChem. 4(3). 445–456. 37 indexed citations
7.
Mai, Knut, Janin Andres, Thomas Bobbert, et al.. (2009). Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21. Diabetes. 58(7). 1532–1538. 131 indexed citations
8.
Foryst‐Ludwig, Anna, Markus Clemenz, Stephan Hohmann, et al.. (2008). Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ. PLoS Genetics. 4(6). e1000108–e1000108. 237 indexed citations
9.
Clemenz, Markus, Nikolaj Frost, Michael Schupp, et al.. (2008). Liver-Specific Peroxisome Proliferator–Activated Receptor α Target Gene Regulation by the Angiotensin Type 1 Receptor Blocker Telmisartan. Diabetes. 57(5). 1405–1413. 72 indexed citations
10.
Kintscher, Ulrich, Martin Hartge, Katharina Heß, et al.. (2008). T-lymphocyte Infiltration in Visceral Adipose Tissue. Arteriosclerosis Thrombosis and Vascular Biology. 28(7). 1304–1310. 562 indexed citations breakdown →
11.
Kappert, Kai, Heike Meýborg, Markus Clemenz, et al.. (2007). Insulin facilitates monocyte migration: A possible link to tissue inflammation in insulin-resistance. Biochemical and Biophysical Research Communications. 365(3). 503–508. 34 indexed citations
12.
Walcher, Daniel, Katharina Heß, Ulrich Kintscher, et al.. (2007). Telmisartan Inhibits CD4-Positive Lymphocyte Migration Independent of the Angiotensin Type 1 Receptor via Peroxisome Proliferator-Activated Receptor-γ. Hypertension. 51(2). 259–266. 18 indexed citations
13.
Goebel, Matthias, Markus Clemenz, & Thomas Unger. (2006). Effective treatment of hypertension by AT1receptor antagonism: the past and future of telmisartan. Expert Review of Cardiovascular Therapy. 4(5). 615–629. 22 indexed citations
14.
Clasen, R., Michael Schupp, Anna Foryst‐Ludwig, et al.. (2005). PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin. Hypertension. 46(1). 137–143. 230 indexed citations
15.
Schupp, Michael, Markus Clemenz, Romain Gineste, et al.. (2005). Molecular Characterization of New Selective Peroxisome Proliferator–Activated Receptor γ Modulators With Angiotensin Receptor Blocking Activity. Diabetes. 54(12). 3442–3452. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tufail Syed Breakdown of academic impact, for papers by Jason DeFuria Breakdown of academic impact, for papers by Agnès Pernin Breakdown of academic impact, for papers by Adam B. Mayerson Breakdown of academic impact, for papers by Toshiyuki Hibuse Breakdown of academic impact, for papers by Nanlan Luo Breakdown of academic impact, for papers by Federica Sentinelli Breakdown of academic impact, for papers by Martin Hartge Breakdown of academic impact, for papers by Heekyung Chung Breakdown of academic impact, for papers by Silvia Gogg
Rankless by CCL
2026